Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 70Rectal Neoplasms 29Colonic Neoplasms 28Carcinoma, Hepatocellular 26Neoplasm Metastasis 15Stomach Neoplasms 12Pancreatic Neoplasms 7Cholangiocarcinoma 6Adenocarcinoma Of Esophagus 6Esophageal Neoplasms 5Recurrence 4Liver Neoplasms 4Biliary Tract Neoplasms 4Neoplasms 3Esophageal Squamous Cell Carcinoma 3Peritoneal Neoplasms 2Neoplastic Cells, Circulating 2Gastrointestinal Neoplasms 2Colorectal Cancer Metastatic 2Cirrhosis, Familial, with Pulmonary Hypertension 2Adenocarcinoma 2Postoperative Complications 1Peripheral Nervous System Diseases 1Pathologic Complete Response 1Pancreatic Adenocarcinoma 1Operable T2-3N+M0 Rectal Cancer (Stage III) 1Oligometastatic Gastric Adenocarcinoma 1Neurotoxicity Syndromes 1Neuropathy, Painful 1Neuralgia 1

Interventions

Cisplatin 86Radiotherapy 71Paclitaxel 50Fluorouracil 38Carboplatin 36Drug Therapy 32Neoadjuvant Therapy 23toripalimab 19tislelizumab 18pembrolizumab 17camrelizumab 17Irinotecan 17Esophagectomy 17Surgical Procedures, Operative 16Radiation 16Docetaxel 16sintilimab 15Oxaliplatin 14130-nm albumin-bound paclitaxel 14nimotuzumab 11TP protocol 11S 1 (combination) 11Radiotherapy, Intensity-Modulated 11Cetuximab 11Capecitabine 11Albumin-Bound Paclitaxel 10apatinib 9Leucovorin 9Immune Checkpoint Inhibitors 8nedaplatin 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Esophageal Squamous Cell Carcinoma × Folfox protocol × Clear all
NCT00381706 2021-09-29

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
245 enrolled 15 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01248299 2019-05-16

E-DIS

Centre Oscar Lambret

Phase 2 Terminated
105 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT01605305 2012-05-24

Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer

Fudan University

Phase 2 Completed
60 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡